The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Net Asset Value - March 2020

10 Jun 2020 11:04

RNS Number : 5448P
JPEL Private Equity Limited
10 June 2020
 

JPEL Private Equity Limited

Ground Floor

Cambridge House

Le Truchot, St Peter Port

Guernsey, GY1 1WD

www.jpelonline.com 

 

Regulatory News Service

London Stock Exchange

London

EC2N 1HP

 

 

10 June 2020

 

 

Notice to Shareholders - Net Asset Value for March 2020

 

JPEL Private Equity Limited ("JPEL" or the "Company") has released the Company's Net Asset Value and Quarter End Review for the period ending 31 March 2020.

 

Please find detailed below the estimated net asset value per share for JPEL Private Equity Limited as at 31 March 2020:

Ordinary Share Class - $1.61

 

Shareholders may access an electronic copy of the Quarter End Review at www.jpelonline.com by clicking the "Investor Information" link on the home page and then clicking the "Reports" link. An electronic copy of the Quarter End Review is also attached to this notice.

 

http://www.rns-pdf.londonstockexchange.com/rns/5448P_1-2020-6-10.pdf

 

 

* * *

 

About JPEL Private Equity Limited

 

JPEL Private Equity Limited is a Guernsey registered and incorporated, London Stock Exchange-listed, closed-ended investment company (LSE: JPEL) designed primarily to invest in the global private equity market. The investment objective of the Company is to achieve both short and long-term capital appreciation by investing in a well diversified portfolio of private equity fund interests and by capitalising on the inefficiencies of the secondary private equity market.

 

 

 

ENQUIRIES:

 

FCF JPEL Management LLC

JPELClientService@fortress.com

 

Rosemary DeRise

+1 212 497 2908

RDeRise@fortress.com 

 

Samantha Ladd Sughrue

+1 212 497 2983

SSughrue@fortress.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NAVGZGMVGGZGGZM

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.